Blog: MS news

NICE pauses final decision on ocrelizumab for primary progressive MS

2 November 2018

Source MS Trust: NICE has announced that it is pausing the publication of final guidance for ocrelizumab for primary progressive multiple sclerosis.

Novartis files MS drug siponimod in EU and US

10 October 2018

Source PharmaTimes: "Siponimod is the first investigational medicine to show a significant delay in disability progression in typical SPMS patients," said Paul Hudson, chief executive of Novartis Pharmaceuticals. "We are closely working with the FDA and EMA to ensure siponimod is available for patients as soon as possible."

Medical Cannabis To Be Available On Prescription ‘Within Weeks’

10 October 2018

Source Huffington Post: Medical cannabis will be available on prescription in the UK within a month, according to The Telegraph.

Former watchdog chief labels disabled benefits process a 'hostile environment'

10 October 2018

Source The Guardian: Andrew McDonald, who chaired Independent Parliamentary Standards Authority, says the system is ‘Kafka-esque’

New 8 Week Wednesday Pilates Class!

3 October 2018

We are starting a new temporary pilates class on Wednesdays 3.00pm - 4.00pm. The class will run from the 31st October up to and including19th December. Criteria: Ability to get on and off the floor with minimal assistance.

Encouraging news for people with primary or secondary progressive MS

3 October 2018

Source F1000 Prime: Fox et al. present the results of the eagerly awaited SPRINT-MS trial – a multi-centre phase II double blinded placebo controlled study of ibudilast in decreasing brain atrophy in progressive forms of multiple sclerosis (MS).

Making a lasting power of attorney has never been easier!

2 October 2018

Making a lasting power of attorney for your health and wellbeing and financial affairs has never been easier! You may never need it, but it's a good idea to plan ahead just in case!

Pages

Category

Archive